Literature DB >> 2717615

Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer-leaflet lipid by prothrombinase complex formation.

J Connor1, C Bucana, I J Fidler, A J Schroit.   

Abstract

Phosphatidylserine (PS) is asymmetrically distributed in mammalian cell membranes, being preferentially localized in the inner leaflet. Some studies have suggested that a disturbance in the normal asymmetric distribution of PS--e.g., PS exposure in the outer leaflet of the cell membrane, which can occur upon platelet activation as well as in certain pathologic red cells--serves as a potent procoagulant surface and as a signal for triggering their recognition by macrophages. These studies suggest that the regulation of PS distribution in cell membranes may be critical in controlling coagulation and in determining the survival of pathologic cells in the circulation. In this paper we describe a sensitive technique, based on PS-dependent prothrombinase complex activity, for assessing the amount of PS on the external leaflet of intact viable cells. Our results indicate that tumorigenic, undifferentiated murine erythroleukemic cells express 7- to 8-fold more PS in their outer leaflet than do their differentiated, nontumorigenic counterparts. Increased expression of PS in the tumorigenic cells directly correlated with their ability to be recognized and bound by macrophages.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2717615      PMCID: PMC287091          DOI: 10.1073/pnas.86.9.3184

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  Lipid asymmetry in membranes.

Authors:  J A Op den Kamp
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

Review 2.  Erythroleukemic differentiation.

Authors:  P A Marks; R A Rifkind
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

3.  Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets.

Authors:  E M Bevers; P Comfurius; J L van Rijn; H C Hemker; R F Zwaal
Journal:  Eur J Biochem       Date:  1982-02

4.  Abnormalities in membrane phospholipid organization in sickled erythrocytes.

Authors:  B Lubin; D Chiu; J Bastacky; B Roelofsen; L L Van Deenen
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

5.  Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages.

Authors:  A Raz; C Bucana; W E Fogler; G Poste; I J Fidler
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

6.  Isolation and characterization of single chain bovine factor V.

Authors:  M E Nesheim; K H Myrmel; L Hibbard; K G Mann
Journal:  J Biol Chem       Date:  1979-01-25       Impact factor: 5.157

7.  Erythrocyte membrane lipid reorganization during the sickling process.

Authors:  D Chiu; B Lubin; S B Shohet
Journal:  Br J Haematol       Date:  1979-02       Impact factor: 6.998

8.  The role of phospholipids and factor Va in the prothrombinase complex.

Authors:  J Rosing; G Tans; J W Govers-Riemslag; R F Zwaal; H C Hemker
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

9.  Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.

Authors:  A J Schroit; I J Fidler
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

10.  The enzymatic synthesis of phosphatidylserine and purification by CM-cellulose column chromatography.

Authors:  P Comfurius; R F Zwaal
Journal:  Biochim Biophys Acta       Date:  1977-07-20
View more
  46 in total

1.  Expression of tissue factor procoagulant activity: regulation by cytosolic calcium.

Authors:  R Bach; D B Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

2.  Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47.

Authors:  Mark P Chao; Siddhartha Jaiswal; Rachel Weissman-Tsukamoto; Ash A Alizadeh; Andrew J Gentles; Jens Volkmer; Kipp Weiskopf; Stephen B Willingham; Tal Raveh; Christopher Y Park; Ravindra Majeti; Irving L Weissman
Journal:  Sci Transl Med       Date:  2010-12-22       Impact factor: 17.956

3.  Ions Modulate Key Interactions between pHLIP and Lipid Membranes.

Authors:  Justin Westerfield; Chitrak Gupta; Haden L Scott; Yujie Ye; Alayna Cameron; Blake Mertz; Francisco N Barrera
Journal:  Biophys J       Date:  2019-07-29       Impact factor: 4.033

Review 4.  Imaging and therapeutic applications of zinc(ii)-dipicolylamine molecular probes for anionic biomembranes.

Authors:  Douglas R Rice; Kasey J Clear; Bradley D Smith
Journal:  Chem Commun (Camb)       Date:  2016-07-07       Impact factor: 6.222

5.  Noninvasive measurements of integrin microclustering under altered membrane cholesterol levels.

Authors:  Deepak Dibya; Neha Arora; Emily A Smith
Journal:  Biophys J       Date:  2010-08-04       Impact factor: 4.033

6.  The contribution of a serum component(s) modified by B cells to the mechanism for macrophage activation by liposomes.

Authors:  Y Aramaki; M Murai; S Tsuchiya
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

7.  Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coli.

Authors:  Steen K Fagerberg; Martin R Jakobsen; Marianne Skals; Helle A Praetorius
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

8.  Comparative membrane interaction study of viscotoxins A3, A2 and B from mistletoe (Viscum album) and connections with their structures.

Authors:  Alexandre Coulon; Amor Mosbah; André Lopez; Anne-Marie Sautereau; Gerhard Schaller; Konrad Urech; Pierre Rougé; Hervé Darbon
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

9.  Uptake of phosphatidylserine liposomes by rat Peyer's patches following intraluminal administration.

Authors:  H Tomizawa; Y Aramaki; Y Fujii; T Hara; N Suzuki; K Yachi; H Kikuchi; S Tsuchiya
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

10.  Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model.

Authors:  T C Carneiro-Lobo; S Konig; D E Machado; L E Nasciutti; M F Forni; I M B Francischetti; M C Sogayar; R Q Monteiro
Journal:  J Thromb Haemost       Date:  2009-07-17       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.